As Alphabet prepares to report its Q4 2025 results, investors are weighing whether its soaring stock price—fueled by Gemini AI integration and cloud growth—has already priced in future success, or if more runway remains.
Apple's stellar earnings, driven by robust iPhone demand and growth in key markets, have reignited investor optimism. Yet, a significant valuation gap persists, sparking debate on whether the stock's AI-driven future justifies its current premium.
As YouTube TV prepares a direct assault on the sports streaming market, analysts warn that FuboTV's core business model is under unprecedented threat. With subscriber growth stagnating and financial pressures mounting, the company's path to profitability looks increasingly narrow.
After a period of significant volatility, Neogen Corporation (NEOG) is showing signs of a sustainable operational turnaround under new leadership, with its latest quarterly results beating expectations and prompting a rare guidance upgrade.
While Winter Storm Devin triggered JetBlue's late-December collapse, a closer look reveals a fragile operational system, concentrated network, and strained labor relations that pose significant ongoing risks for the airline and its investors.
Taiwan Semiconductor Manufacturing Company (TSMC) continues to solidify its position as the indispensable engine of the global tech industry. Driven by insatiable AI demand and strategic global expansion, the chipmaking titan's financial performance and long-term outlook are drawing intense investor scrutiny and bullish projections.
Cisco Systems' stock is gaining momentum, fueled by surging demand from hyperscalers building AI data centers. The networking giant's raised guidance and record revenue have triggered a wave of analyst upgrades, positioning it as a key beneficiary of the AI infrastructure build-out.
After a sharp post-earnings sell-off and insider sales, Power Solutions International (PSIX) faces a critical test. Investors are weighing near-term execution risks against the company's strategic positioning in the surging demand for data center power generation.
DLocal Limited's third-quarter results reveal a payments platform hitting its stride, with total payment volume soaring 59% year-over-year to a record $10.4 billion. Strong performance in Latin America and strategic expansions underpin a compelling growth narrative for the emerging markets fintech.
ServiceNow stock rose nearly 1% on Monday, outperforming the broader market, after Goldman Sachs added the workflow software giant to its prestigious Conviction List, citing significant expansion potential into new enterprise software segments.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
The Malaysian snack food manufacturer is posting a notable improvement in its return on capital employed (ROCE), outperforming industry averages and suggesting effective reinvestment strategies that could appeal to long-term investors.
Despite Adtalem Global Education posting robust quarterly results with 34% EPS growth, investment firm Peregrine Asset Advisers has liquidated its entire position, raising questions about the divergence between corporate performance and investor sentiment in the education sector.
A recent SEC filing reveals a major purchase of the Vanguard 0-3 Month Treasury Bill ETF, signaling a strategic move for liquidity and yield in a volatile market.
Investors seeking stability in volatile markets often turn to consumer staples ETFs. We analyze the strategic divergence between Fidelity's broad, low-cost approach and Invesco's targeted, factor-driven fund to determine which might better serve a defensive portfolio.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
DaVita Inc. reported Q4 2025 results in line with expectations, highlighting a milestone first profitable year for its Integrated Kidney Care unit. While revenue per treatment accelerated, the company continues to face pressure from elevated patient mortality and rising benefit costs. Executives provided 2026 guidance projecting mid-single-digit operating income growth and a sharp rise in EPS, buoyed by share buybacks and the stabilization of prior investment losses.
Fabrinet's fiscal Q2 2026 results smashed expectations, fueled by explosive growth in data center interconnect modules and a breakout performance in high-performance computing. The manufacturing services provider raises guidance, signaling strong momentum across its key markets.
Simon Property Group reported robust fourth-quarter results, driven by record funds from operations and resilient leasing demand. The retail REIT giant is steering a multi-billion dollar redevelopment strategy while returning significant capital to shareholders, even as it navigates a cautious outlook for 2026.
